pubmed-article:11314680 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:11314680 | lifeskim:mentions | umls-concept:C0026809 | lld:lifeskim |
pubmed-article:11314680 | lifeskim:mentions | umls-concept:C0004927 | lld:lifeskim |
pubmed-article:11314680 | lifeskim:mentions | umls-concept:C0450442 | lld:lifeskim |
pubmed-article:11314680 | lifeskim:mentions | umls-concept:C1709059 | lld:lifeskim |
pubmed-article:11314680 | lifeskim:mentions | umls-concept:C0599861 | lld:lifeskim |
pubmed-article:11314680 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:11314680 | pubmed:dateCreated | 2001-4-20 | lld:pubmed |
pubmed-article:11314680 | pubmed:abstractText | Inhibition of glutamatergic N-methyl-D-aspartate (NMDA) receptors following the administration of NMDA receptor antagonists results in psychotic-like behaviour. Whereas it is known that pharmacological manipulation of dopaminergic and serotonergic pathways affect this drug-induced psychosis, a role for noradrenaline has not yet been clearly defined. | lld:pubmed |
pubmed-article:11314680 | pubmed:language | eng | lld:pubmed |
pubmed-article:11314680 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11314680 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:11314680 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11314680 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11314680 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11314680 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11314680 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11314680 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11314680 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11314680 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11314680 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11314680 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11314680 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11314680 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11314680 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11314680 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11314680 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:11314680 | pubmed:month | Mar | lld:pubmed |
pubmed-article:11314680 | pubmed:issn | 0033-3158 | lld:pubmed |
pubmed-article:11314680 | pubmed:author | pubmed-author:LeonardB EBE | lld:pubmed |
pubmed-article:11314680 | pubmed:author | pubmed-author:O'DonnellJ... | lld:pubmed |
pubmed-article:11314680 | pubmed:author | pubmed-author:KellyJ PJP | lld:pubmed |
pubmed-article:11314680 | pubmed:author | pubmed-author:MorrisKK | lld:pubmed |
pubmed-article:11314680 | pubmed:author | pubmed-author:HarkinAA | lld:pubmed |
pubmed-article:11314680 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:11314680 | pubmed:day | 1 | lld:pubmed |
pubmed-article:11314680 | pubmed:volume | 154 | lld:pubmed |
pubmed-article:11314680 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:11314680 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:11314680 | pubmed:pagination | 177-88 | lld:pubmed |
pubmed-article:11314680 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:11314680 | pubmed:meshHeading | pubmed-meshheading:11314680... | lld:pubmed |
pubmed-article:11314680 | pubmed:meshHeading | pubmed-meshheading:11314680... | lld:pubmed |
pubmed-article:11314680 | pubmed:meshHeading | pubmed-meshheading:11314680... | lld:pubmed |
pubmed-article:11314680 | pubmed:meshHeading | pubmed-meshheading:11314680... | lld:pubmed |
pubmed-article:11314680 | pubmed:meshHeading | pubmed-meshheading:11314680... | lld:pubmed |
pubmed-article:11314680 | pubmed:meshHeading | pubmed-meshheading:11314680... | lld:pubmed |
pubmed-article:11314680 | pubmed:meshHeading | pubmed-meshheading:11314680... | lld:pubmed |
pubmed-article:11314680 | pubmed:meshHeading | pubmed-meshheading:11314680... | lld:pubmed |
pubmed-article:11314680 | pubmed:meshHeading | pubmed-meshheading:11314680... | lld:pubmed |
pubmed-article:11314680 | pubmed:meshHeading | pubmed-meshheading:11314680... | lld:pubmed |
pubmed-article:11314680 | pubmed:meshHeading | pubmed-meshheading:11314680... | lld:pubmed |
pubmed-article:11314680 | pubmed:meshHeading | pubmed-meshheading:11314680... | lld:pubmed |
pubmed-article:11314680 | pubmed:meshHeading | pubmed-meshheading:11314680... | lld:pubmed |
pubmed-article:11314680 | pubmed:meshHeading | pubmed-meshheading:11314680... | lld:pubmed |
pubmed-article:11314680 | pubmed:meshHeading | pubmed-meshheading:11314680... | lld:pubmed |
pubmed-article:11314680 | pubmed:meshHeading | pubmed-meshheading:11314680... | lld:pubmed |
pubmed-article:11314680 | pubmed:meshHeading | pubmed-meshheading:11314680... | lld:pubmed |
pubmed-article:11314680 | pubmed:meshHeading | pubmed-meshheading:11314680... | lld:pubmed |
pubmed-article:11314680 | pubmed:meshHeading | pubmed-meshheading:11314680... | lld:pubmed |
pubmed-article:11314680 | pubmed:meshHeading | pubmed-meshheading:11314680... | lld:pubmed |
pubmed-article:11314680 | pubmed:year | 2001 | lld:pubmed |
pubmed-article:11314680 | pubmed:articleTitle | Modulation of MK-801-induced behaviour by noradrenergic agents in mice. | lld:pubmed |
pubmed-article:11314680 | pubmed:affiliation | Department of Pharmacology, National University of Ireland, Galway. andrew.harkin@nuigalway.ie | lld:pubmed |
pubmed-article:11314680 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:11314680 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11314680 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11314680 | lld:pubmed |